A Phase 2 Study of Simtuzumab in Patients With Primary, Post-Polycythaemia Vera or Post-Essential Thrombocythaemia Myelofibrosis
British Journal of Haematology - United Kingdom
doi 10.1111/bjh.14501
Full Text
Open PDFAbstract
Available in full text
Categories
Date
February 21, 2017
Authors
Publisher
Wiley